# A Study of CellCept (Mycophenolate Mofetil) Combined With Tacrolimus and Corticosteroids in Kidney Transplant Patients.

> **NCT00758602** · PHASE4 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 210 (actual)

## Conditions studied

- Kidney Transplantation

## Interventions

- **DRUG:** mycophenolate mofetil
- **DRUG:** tacrolimus, standard dose
- **DRUG:** tacrolimus, low dose
- **DRUG:** corticosteroids

## Key facts

- **NCT ID:** NCT00758602
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 210 (ACTUAL)
- **Last updated:** 2014-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00758602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00758602, "A Study of CellCept (Mycophenolate Mofetil) Combined With Tacrolimus and Corticosteroids in Kidney Transplant Patients.". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00758602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*